Aterian PLC - Director/PDMR Share Purchases
Released
RNS Number : 6520J
ATERIAN Plc |
| ||||||||||||
("Aterian ", the "Company" or the "Group")
| |||||||||||||
Director/PDMR Share Purchases |
| ||||||||||||
Aterian Plc (LSE: ATN),the exploration and development company advancing its portfolio of African-focused critical and strategic metal assets was informed on 10 August 2023 of the following purchases of the Company's ordinary shares by Directors and PDMRs of the Company.
| |||||||||||||
The purchases made on 10 August 2023 are detailed below:
| |||||||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated |
| ||||||||||
| a) | Name | Charles Bray |
| |||||||||
| 2. | Reason for the notification |
| ||||||||||
| a) | Position/status | PDMR, Director |
| |||||||||
| b) | Initial notification / Amendment |
| ||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
| ||||||||||
| a) | Name | Aterian plc |
| |||||||||
| b) | LEI | 2138005GAARIE1JMP262 |
| |||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
| ||||||||||
| a) | Description of the financial instrument, type of instrument | Ordinary Shares |
| |||||||||
| Identification code | ISIN: GB00BKS7ZV87 |
| ||||||||||
| b) | Nature of the transaction | Purchase of shares |
| |||||||||
| c) | Price(s) and volume(s) |
|
| |||||||||
| d) | Aggregate information |
| ||||||||||
| - Aggregate volume | 20,000,000 shares in aggregate |
| ||||||||||
| - Total Price | £200,000 |
| ||||||||||
| e) | Date of the transaction | 10/08/2023 |
| |||||||||
| f) | Place of the transaction | London Stock Exchange |
| |||||||||
| g) | Additional information | NA |
| |||||||||
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the
use the personal data you provide us, please see our Privacy Policy.
END
DSHPRMLTMTABMJJ
Share your feedback
Discover